AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT102.10-0.99 (-0.96%) ▼|ACN194.76-0.26 (-0.13%) ▼|ADBE262.39-3.22 (-1.21%) ▼|AMAT424.14-0.07 (-0.02%) ▼|AMD503.99+10.58 (+2.14%) ▲|AMGN377.06-4.44 (-1.16%) ▼|AMT177.54+0.47 (+0.27%) ▲|AMZN252.65-0.89 (-0.35%) ▼|AVGO345.70+0.98 (+0.28%) ▲|AXP326.17-1.65 (-0.50%) ▼|BA209.76-0.53 (-0.25%) ▼|BAC59.10-0.37 (-0.62%) ▼|BKNG173.34-2.01 (-1.15%) ▼|BLK1,058.92-6.93 (-0.65%) ▼|BMY63.47-0.64 (-0.99%) ▼|BNY155.10-2.57 (-1.63%) ▼|BRK-B514.82-0.08 (-0.02%) ▼|C138.43+2.23 (+1.64%) ▲|CAT783.85+0.03 (+0.00%) ▲|CL86.64-1.25 (-1.42%) ▼|CMCSA24.66-0.23 (-0.90%) ▼|COF208.59+1.86 (+0.90%) ▲|COP139.40+2.73 (+2.00%) ▲|COST912.71-6.20 (-0.67%) ▼|CRM259.89+0.59 (+0.23%) ▲|CSCO110.90+0.84 (+0.76%) ▲|CVS93.92-1.63 (-1.71%) ▼|CVX215.15+2.99 (+1.41%) ▲|DE686.61+4.94 (+0.72%) ▲|DHR205.60+2.30 (+1.13%) ▲|DIS107.55-1.04 (-0.95%) ▼|DUK118.11-0.92 (-0.77%) ▼|EMR147.37-0.95 (-0.64%) ▼|FDX312.40-0.21 (-0.07%) ▼|GD354.76-2.08 (-0.58%) ▼|GE314.43-3.13 (-0.98%) ▼|GEV881.23+6.57 (+0.75%) ▲|GILD143.82-1.78 (-1.22%) ▼|GM87.37+0.20 (+0.23%) ▲|GOOG343.05-2.66 (-0.77%) ▼|GOOGL346.68-2.71 (-0.78%) ▼|GS976.33-11.91 (-1.21%) ▼|HD307.64-3.29 (-1.06%) ▼|HON200.43-0.95 (-0.47%) ▼|IBM248.90-0.24 (-0.10%) ▼|INTC99.55+2.36 (+2.43%) ▲|INTU337.29-1.87 (-0.55%) ▼|ISRG372.92-5.02 (-1.33%) ▼|JNJ261.64-4.70 (-1.76%) ▼|JPM348.84-1.31 (-0.37%) ▼|KO88.48-0.36 (-0.40%) ▼|LIN460.13-4.28 (-0.92%) ▼|LLY1,150.30+13.15 (+1.16%) ▲|LMT529.66+0.21 (+0.04%) ▲|LOW195.34-2.85 (-1.44%) ▼|LRCX272.21-1.29 (-0.47%) ▼|MA573.04-1.41 (-0.25%) ▼|MCD255.66-1.85 (-0.72%) ▼|MDLZ62.11-0.28 (-0.45%) ▼|MDT93.36-0.49 (-0.52%) ▼|META672.71+7.11 (+1.07%) ▲|MMM161.08-0.95 (-0.58%) ▼|MO68.62-2.00 (-2.83%) ▼|MRK142.53-1.50 (-1.04%) ▼|MS203.94-2.66 (-1.29%) ▼|MSFT504.72-0.69 (-0.14%) ▼|MU929.93+5.90 (+0.64%) ▲|NEE81.16-0.48 (-0.59%) ▼|NFLX78.76-1.56 (-1.94%) ▼|NKE36.54-0.54 (-1.44%) ▼|NOW141.52-0.83 (-0.58%) ▼|NVDA213.27+2.31 (+1.10%) ▲|ORCL142.41-2.31 (-1.60%) ▼|PEP135.25-1.09 (-0.80%) ▼|PFE27.37-0.36 (-1.30%) ▼|PG144.13-2.03 (-1.39%) ▼|PLTR172.21-1.10 (-0.63%) ▼|PM191.10-3.79 (-1.94%) ▼|QCOM187.87+7.72 (+4.29%) ▲|RTX194.00-1.34 (-0.69%) ▼|SBUX97.95-1.12 (-1.13%) ▼|SCHW107.86+0.55 (+0.51%) ▲|SO86.67-0.34 (-0.39%) ▼|SPG203.35-1.62 (-0.79%) ▼|T26.63+0.12 (+0.43%) ▲|TMO632.86+19.56 (+3.19%) ▲|TMUS183.12+0.22 (+0.12%) ▲|TSLA361.04+2.07 (+0.58%) ▲|TXN265.19+1.77 (+0.67%) ▲|UBER72.22-0.42 (-0.57%) ▼|UNH378.73-4.83 (-1.26%) ▼|UNP283.26-1.82 (-0.64%) ▼|UPS102.44-0.02 (-0.02%) ▼|USB62.95+0.27 (+0.42%) ▲|V374.57-0.72 (-0.19%) ▼|VZ51.29-0.01 (-0.01%) ▼|WFC91.14+2.43 (+2.74%) ▲|WMT108.52-0.56 (-0.51%) ▼|XOM167.23+2.17 (+1.31%) ▲|AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT102.10-0.99 (-0.96%) ▼|ACN194.76-0.26 (-0.13%) ▼|ADBE262.39-3.22 (-1.21%) ▼|AMAT424.14-0.07 (-0.02%) ▼|AMD503.99+10.58 (+2.14%) ▲|AMGN377.06-4.44 (-1.16%) ▼|AMT177.54+0.47 (+0.27%) ▲|AMZN252.65-0.89 (-0.35%) ▼|AVGO345.70+0.98 (+0.28%) ▲|AXP326.17-1.65 (-0.50%) ▼|BA209.76-0.53 (-0.25%) ▼|BAC59.10-0.37 (-0.62%) ▼|BKNG173.34-2.01 (-1.15%) ▼|BLK1,058.92-6.93 (-0.65%) ▼|BMY63.47-0.64 (-0.99%) ▼|BNY155.10-2.57 (-1.63%) ▼|BRK-B514.82-0.08 (-0.02%) ▼|C138.43+2.23 (+1.64%) ▲|CAT783.85+0.03 (+0.00%) ▲|CL86.64-1.25 (-1.42%) ▼|CMCSA24.66-0.23 (-0.90%) ▼|COF208.59+1.86 (+0.90%) ▲|COP139.40+2.73 (+2.00%) ▲|COST912.71-6.20 (-0.67%) ▼|CRM259.89+0.59 (+0.23%) ▲|CSCO110.90+0.84 (+0.76%) ▲|CVS93.92-1.63 (-1.71%) ▼|CVX215.15+2.99 (+1.41%) ▲|DE686.61+4.94 (+0.72%) ▲|DHR205.60+2.30 (+1.13%) ▲|DIS107.55-1.04 (-0.95%) ▼|DUK118.11-0.92 (-0.77%) ▼|EMR147.37-0.95 (-0.64%) ▼|FDX312.40-0.21 (-0.07%) ▼|GD354.76-2.08 (-0.58%) ▼|GE314.43-3.13 (-0.98%) ▼|GEV881.23+6.57 (+0.75%) ▲|GILD143.82-1.78 (-1.22%) ▼|GM87.37+0.20 (+0.23%) ▲|GOOG343.05-2.66 (-0.77%) ▼|GOOGL346.68-2.71 (-0.78%) ▼|GS976.33-11.91 (-1.21%) ▼|HD307.64-3.29 (-1.06%) ▼|HON200.43-0.95 (-0.47%) ▼|IBM248.90-0.24 (-0.10%) ▼|INTC99.55+2.36 (+2.43%) ▲|INTU337.29-1.87 (-0.55%) ▼|ISRG372.92-5.02 (-1.33%) ▼|JNJ261.64-4.70 (-1.76%) ▼|JPM348.84-1.31 (-0.37%) ▼|KO88.48-0.36 (-0.40%) ▼|LIN460.13-4.28 (-0.92%) ▼|LLY1,150.30+13.15 (+1.16%) ▲|LMT529.66+0.21 (+0.04%) ▲|LOW195.34-2.85 (-1.44%) ▼|LRCX272.21-1.29 (-0.47%) ▼|MA573.04-1.41 (-0.25%) ▼|MCD255.66-1.85 (-0.72%) ▼|MDLZ62.11-0.28 (-0.45%) ▼|MDT93.36-0.49 (-0.52%) ▼|META672.71+7.11 (+1.07%) ▲|MMM161.08-0.95 (-0.58%) ▼|MO68.62-2.00 (-2.83%) ▼|MRK142.53-1.50 (-1.04%) ▼|MS203.94-2.66 (-1.29%) ▼|MSFT504.72-0.69 (-0.14%) ▼|MU929.93+5.90 (+0.64%) ▲|NEE81.16-0.48 (-0.59%) ▼|NFLX78.76-1.56 (-1.94%) ▼|NKE36.54-0.54 (-1.44%) ▼|NOW141.52-0.83 (-0.58%) ▼|NVDA213.27+2.31 (+1.10%) ▲|ORCL142.41-2.31 (-1.60%) ▼|PEP135.25-1.09 (-0.80%) ▼|PFE27.37-0.36 (-1.30%) ▼|PG144.13-2.03 (-1.39%) ▼|PLTR172.21-1.10 (-0.63%) ▼|PM191.10-3.79 (-1.94%) ▼|QCOM187.87+7.72 (+4.29%) ▲|RTX194.00-1.34 (-0.69%) ▼|SBUX97.95-1.12 (-1.13%) ▼|SCHW107.86+0.55 (+0.51%) ▲|SO86.67-0.34 (-0.39%) ▼|SPG203.35-1.62 (-0.79%) ▼|T26.63+0.12 (+0.43%) ▲|TMO632.86+19.56 (+3.19%) ▲|TMUS183.12+0.22 (+0.12%) ▲|TSLA361.04+2.07 (+0.58%) ▲|TXN265.19+1.77 (+0.67%) ▲|UBER72.22-0.42 (-0.57%) ▼|UNH378.73-4.83 (-1.26%) ▼|UNP283.26-1.82 (-0.64%) ▼|UPS102.44-0.02 (-0.02%) ▼|USB62.95+0.27 (+0.42%) ▲|V374.57-0.72 (-0.19%) ▼|VZ51.29-0.01 (-0.01%) ▼|WFC91.14+2.43 (+2.74%) ▲|WMT108.52-0.56 (-0.51%) ▼|XOM167.23+2.17 (+1.31%) ▲|
16.7 C
New York
Tuesday, September 15, 2026

Tag: Complex

newssourceFORcompanyinformationcontent1releasesmarket

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual...

Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clinically meaningful weight reductionsSubstantial improvements in insulin resistance were also...

Rivalry Reports Q1 2025 Results Highlighting Strengthened Unit Economics, Operating Leverage, and Strategic Progress

Operating expenses reduced 58% YoY and net loss narrowed 43% as Rivalry emerges a lean, high-performance engine built for scale, with Q2 setting new records in key user metrics 
Operating expenses reduced 58% YoY and net loss narrowed 43% as Rivalry emerges a lean, high-performance engine built for scale, with Q2 setting new records in key user metrics

DeFi Development Corp. to Host X Spaces Event: “Our First SPS Forecast, Convertible Note Breakdown, & Company Update”

BOCA RATON, FL, July 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Tuesday, July 15, 2025, at 1:30 p.m. Eastern Time, titled “DFDV Guidance Drop: First Forecasts, Convertible Note, & Company Update.”

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 15, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

EnerCom Denver Releases Full Presenter Lineup for Landmark 30th Energy Investment Conference

Conference Lineup Features C-Suite Representation from over 75 Confirmed Companies Industry Panel Topics Include The Resurgence of Exploration, Private Companies, The Rise of Asset-Backed Securitization and Private...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

Health Union Launches 2025 Social Health Awards: Elevating Healthcare’s Unsung Voices

Premier Program to Spotlight Health Leaders Driving Transformative Change in Digital Health PHILADELPHIA, July 14, 2025 /PRNewswire/ -- As a leader in online health communities and...

Lighting the Way: Profoto Selects Barrett Distribution Centers as Its U.S. 3PL Partner

FRANKLIN, Mass., July 14, 2025 /PRNewswire/ -- Profoto, the global leader in light-shaping technology for imaging professionals, has selected Barrett Distribution Centers as its...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

Bandwidth to Report Second Quarter 2025 Financial Results on July 29, 2025

RALEIGH, N.C., July 14, 2025 /PRNewswire/ -- Bandwidth Inc. (NASDAQ: BAND), a leading global enterprise cloud communications company, today announced it will report its...

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger initiative aimed at positioning the company for growth in the burgeoning addiction therapeutics sector.

Perfume Ingredient Chemicals Market to Reach USD 11.43 Billion by 2032, Reports Credence Research

PUNE, India, July 14, 2025 /PRNewswire/ -- According to the latest market analysis published by Credence Research, the global Perfume Ingredient Chemicals Market is...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsComplex

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers